Meta‐analysis of prognostic factors for patients with colorectal peritoneal metastasis undergoing cytoreductive surgery and heated intraperitoneal chemotherapy
Background Up to 15 per cent of colorectal cancers present with peritoneal metastases (CPM). Cytoreductive surgery and heated intraperitoneal chemotherapy (CRS + HIPEC) aims to achieve macroscopic tumour resection combined with HIPEC to destroy microscopic disease. CRS + HIPEC is a major operation w...
Main Authors: | S. Hallam, R. Tyler, M. Price, A. Beggs, H. Youssef |
---|---|
Format: | Article |
Language: | English |
Published: |
Oxford University Press
2019-10-01
|
Series: | BJS Open |
Online Access: | https://doi.org/10.1002/bjs5.50179 |
Similar Items
-
Peritoneal carcinomatosis treated with cytoreductive surgery and intraperitoneal chemotherapy
by: Bernardo Hanan, et al.
Published: (2018-04-01) -
The importance of synchronicity in the management of colorectal peritoneal metastases with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
by: Jolene Si Min Wong, et al.
Published: (2020-01-01) -
Treatment of intraoperatively detected peritoneal carcinomatosis of colorectal origin with cytoreductive surgery and intraperitoneal chemotherapy
by: Aras Emre Canda, et al.
Published: (2018-03-01) -
Perioperative management and postoperative outcome of patients undergoing cytoreduction surgery with hyperthermic intraperitoneal chemotherapy
by: Hamed Elgendy, et al.
Published: (2019-01-01) -
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer
by: Loss Martin, et al.
Published: (2004-06-01)